China’s NMPA approves Akeso’s gumokimab for plaque psoriasis
The approval is based on data from one pivotal Phase III study (AK111-301) and three additional supportive studies.
Drug Development
FDA grants priority review for Roche’s Tecentriq combo sBLA
XtalPi enters $400m partnership for small molecule therapy for GPCR target
EMA validates Bayer’s asundexian application for ischaemic stroke
Coya Therapeutics CEO on ALS urgency and fast-tracking COYA 302 for patient impact
Aditxt and Ignite announce merger plans with strategic partner
MHRA to roll out new AI sandbox for medicines development
J&J to acquire Firefly Bio for $1bn to enhance oncology pipeline
